Bone marrow progenitor cell therapy-mediated paracrine regulation of cardiac miRNA-155 modulates fibrotic response in diabetic hearts.

Bone marrow progenitor cell therapy-mediated paracrine regulation of cardiac miRNA-155 modulates fibrotic response in diabetic hearts.

Diabetes is associated with a higher incidence of myocardial infarction (MI) and increased risk for adverse vascular and fibrogenic events post-MI. Bone marrow-derived progenitor cell (BMPC) therapy has been shown to promote neovascularization, decrease infarct area and attenuate left ventricular (L...

Full description

Bibliographic Details
Main Authors: Raj Kishore, Suresh K Verma, Alexander R Mackie, Erin E Vaughan, Tatiana V Abramova, Ito Aiko, Prasanna Krishnamurthy
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3613379?pdf=render

Internet

http://europepmc.org/articles/PMC3613379?pdf=render

Similar Items